26 comparative SP vs MP RARP studies: lower estimated blood loss (SMD 0.51), shorter hospital stay (SMD 1.12), lower post-operative pain scores (SMD 0.12), with comparable continence, potency, positive margin, and biochemical recurrence at reported follow-up.